Singapore: Australia-based Bone Medical, a biopharmaceutical company focused on the development of new medicines for mus...
Singapore: A research conducted by Australian scientists on stem cells has shown that patients suffering from type 1 dia...
Australia: Australia based regenerative medicine company, Orthocell, has successfully grown human tendons in a laborator...
Singapore: Ahead of the 21st International AIDS Conference, a team of Australian researchers and experts from the Austra...
Singapore: As representatives from the United States and 11 other Pacific-Rim countries gather in New Zealand to sign th...
Healthe Care, Australia's third largest private healthcare group, officially became a member of Singapore-headquartered,...
Singapore: Sugar Research Australia recently announced a new research partnership with India to further research and fos...
Singapore: QRxPharma has clarified with the US FDA about the steps necessary for approval of immediate release Moxduo. ...
Steering Bionomics' focus towards large markets where there is a defined clinical need for new treatments, Dr Rathjen he...
Singapore: US-based Cytori Therapeutics and China-based Lorem Vascular have formed a partnership to commercialize Cytori...
Singapore: An effective new antibiotic designed to specifically treat Clostridium difficile-associated diarrhoea will be...
Singapore: Generon (Shanghai)has initiated phase I clinical trial for F-652 in Australia. F-652 is a recombinant protein...
Singapore: Australian drug delivery technology company Imugene has received key Chinese patent application for the compa...
Singapore: Spinifex Pharmaceuticals, an Australian pain drug development company, announced that the first set of patie...
Singapore: Australia-based Reva Medical has initiated enrolment of patients for its ReZolve 2 bioresorbable scaffold at ...
Singapore: Australian company CSL Behring has submitted a variation application to the European Medicines Agency (EMA) f...
Singapore: A treatment for patients with chronic myeloid leukaemia (CML) and Philadelphia chromosome positive acute lymp...
Singapore: The Asia-Pacific (APAC) breast cancer market is set to experience considerable expansion from $1.9 billion in...
